Trial intelligence / Profile preview

Impact of Intravenous Dexamethasone on the Duration of Motor and Sensory Block Following Spinal Anesthesia With Chloroprocaine

NCT07837674Not yet recruiting

Sponsor
Centre hospitalier de l’Université de Montréal
Start
Nov 2026
Primary completion
Nov 2027
Countries
1
01

Overview

Randomised, double-blind trial of dexamethasone in spinal anesthesia (2 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Regression of sensory block by 2 dermatomes. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

dexamethasone
03

Conditions

spinal anesthesia

Beyond the preview

Go deeper on NCT07837674.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07837674.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call